Inventor
PLATT DAVID
US37 patents
⚠️ This page may combine multiple inventors who share the name “PLATT DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PLATT DAVID
7 patentsUS8236780B2Aug 7, 2012
Galactose—pronged polysaccharides in a formulation for antifibrotic therapies
PLATT DAVID39 citations97
US7491708B1Feb 17, 2009
Modified pectin
PLATT DAVID20 citations92
US8722645B2May 13, 2014
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
PLATT DAVID8 citations83
US10846688B2Nov 24, 2020
Method for granting access to a communications network in exchange for performing tasks associated with the communications network
PLATT DAVID1 citations62
US5759992AJun 2, 1998
Immunotherapeutic agent derived from bacteria and method for its manufacture
PLATT DAVID3 citations62
US11288746B2Mar 29, 2022
Method for granting access to a communications network in exchange for performing tasks associated with the communications network
PLATT DAVID0 citations52
US11111665B2Sep 7, 2021
Composite insulation batt
PLATT DAVID0 citations52
TIVO INC
5 patentsUS6757837B1Jun 29, 2004
Method and apparatus for software failure diagnosis and repair
TIVO INC292 citations98
US6385739B1May 7, 2002
Self-test electronic assembly and test system
TIVO INC141 citations97
US6643798B2Nov 4, 2003
Self-test electronic assembly and test system
TIVO INC70 citations94
US7216235B1May 8, 2007
Drive/host locking system
TIVO INC25 citations92
US9424264B2Aug 23, 2016
Hierarchical tags with community-based ratings
TIVO INC10 citations84
(unassigned)
5 patentsUS6423314B2Jul 23, 2002
Tumor derived carbohydrate binding protein
23 citations92
US5681923AOct 28, 1997
Tumor derived carbohydrate binding protein
29 citations92
US6914055B2Jul 5, 2005
Delivery of a therapeutic agent in a formulation for reduced toxicity
12 citations83
US5891861AApr 6, 1999
Composition and method for treating fungal disease in animals
16 citations74
US6245316B1Jun 12, 2001
Enhancement of delivery of radioimaging and radioprotective agents
0 citations52
PRO PHARMACEUTICALS INC
4 patentsUS7893252B2Feb 22, 2011
Selectively depolymerized galactomannan polysaccharide
PRO PHARMACEUTICALS INC27 citations91
US7012068B2Mar 14, 2006
Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
PRO PHARMACEUTICALS INC16 citations83
US6645946B1Nov 11, 2003
Delivery of a therapeutic agent in a formulation for reduced toxicity
PRO PHARMACEUTICALS INC17 citations83
US6642205B2Nov 4, 2003
Methods and compositions for reducing side effects in chemotherapeutic treatments
PRO PHARMACEUTICALS INC15 citations83
GALECTIN THERAPEUTICS INC
3 patentsUS9200090B2Dec 1, 2015
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC4 citations83
US8367638B2Feb 5, 2013
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC1 citations62
US10744154B2Aug 18, 2020
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
GALECTIN THERAPEUTICS INC0 citations51